| PERSPECTIVE THERAPEUTICS |
| USA |
| Gesundheit |
| US46489V3024 / A40EDR |
| AAJ0 (Frankfurt) |
| FRA:AAJ0, ETR:AAJ0, AAJ0:GR |
| - |
| https://perspectivetherap.. |
|
Perspective Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics and technologies to treat various diseases, primarily within the oncology sector. Its primary function is..
>Volltext.. |
| 308.55 Mio. EUR |
| 78.52 Mio. EUR |
| 0.54 Mio. EUR |
| -93.13 Mio. EUR |
| -97.3 Mio. EUR |
| -1.22 EUR |
| 3.7 Mio. EUR |
| 47.26 Mio. EUR |
| -80.87 Mio. EUR |
| 8.6 |
| -60.66% |
| -22.18% |
| - |
| - |
| - |
| - |
| PERSPECTIVE THERAPEUTICS, PERSPECTIVE THERAPEUTIC |
| 16.07.26 |
|